These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11248767)

  • 21. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of chronic therapy with cardiac contractility modulation electrical signals on cytoskeletal proteins and matrix metalloproteinases in dogs with heart failure.
    Rastogi S; Mishra S; Zacà V; Mika Y; Rousso B; Sabbah HN
    Cardiology; 2008; 110(4):230-7. PubMed ID: 18073477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.
    Mann JA; Abraham WT
    Curr Heart Fail Rep; 2019 Feb; 16(1):38-46. PubMed ID: 30762177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A translational assessment of preclinical versus clinical tools for the measurement of cardiac contractility: comparison of LV dP/dt(max) with echocardiography in telemetry implanted beagle dogs.
    Cools F; Dhuyvetter D; Vanlommel A; Janssens S; Borghys H; Geys H; Gallacher DJ
    J Pharmacol Toxicol Methods; 2014; 69(1):17-23. PubMed ID: 24140387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizer Smart in the treatment of moderate-to-severe chronic heart failure.
    Campbell CM; Kahwash R; Abraham WT
    Future Cardiol; 2020 Jan; 16(1):13-25. PubMed ID: 31825245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ca(2+)-binding proteins in dogs with heart failure: effects of cardiac contractility modulation electrical signals.
    Gupta RC; Mishra S; Rastogi S; Wang M; Rousso B; Mika Y; Remppis A; Sabbah HN
    Clin Transl Sci; 2009 Jun; 2(3):211-5. PubMed ID: 20443895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac contractility modulation in non-responders to cardiac resynchronization therapy.
    Nägele H; Behrens S; Eisermann C
    Europace; 2008 Dec; 10(12):1375-80. PubMed ID: 18776196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global improvement in left ventricular performance observed with cardiac contractility modulation is the result of changes in regional contractility.
    Callans DJ; Fuchs S; Mika Y; Shemer I; Aviv R; Haddad W; Darvish N; Ben-Haim SA; Kornowski R
    Heart Fail Rev; 2001 Jan; 6(1):35-44. PubMed ID: 11248766
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Pappone C; Rosanio S; Burkhoff D; Mika Y; Vicedomini G; Augello G; Shemer I; Prutchi D; Haddad W; Aviv R; Snir Y; Kronzon I; Alfieri O; Ben-Haim SA
    Am J Cardiol; 2002 Dec; 90(12):1307-13. PubMed ID: 12480039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging role of cardiac contractility modulation in heart failure treatment.
    Chinyere IR; Balakrishnan M; Hutchinson MD
    Curr Opin Cardiol; 2022 Jan; 37(1):30-35. PubMed ID: 34698667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction.
    Anker SD; Borggrefe M; Neuser H; Ohlow MA; Röger S; Goette A; Remppis BA; Kuck KH; Najarian KB; Gutterman DD; Rousso B; Burkhoff D; Hasenfuss G
    Eur J Heart Fail; 2019 Sep; 21(9):1103-1113. PubMed ID: 30652394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: an individual patient's data meta-analysis of randomized controlled trials.
    Giallauria F; Vigorito C; Piepoli MF; Stewart Coats AJ
    Int J Cardiol; 2014 Aug; 175(2):352-7. PubMed ID: 24975782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of epivascular cardiac autonomic nerve stimulation on cardiac function.
    Kobayashi M; Sakurai S; Takaseya T; Shiose A; Kim HI; Fujiki M; Karimov JH; Dessoffy R; Massiello A; Borowski AG; Van Wagoner DR; Jung EJ; Fukamachi K
    Ann Thorac Surg; 2012 Oct; 94(4):1150-6. PubMed ID: 22939448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac contractility modulation in patients with advanced heart failure.
    Kahwash R; Burkhoff D; Abraham WT
    Expert Rev Cardiovasc Ther; 2013 May; 11(5):635-45. PubMed ID: 23621145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biventricular pacing cardiac contractility modulation improves cardiac contractile function via upregulating SERCA2 and miR-133 in a rabbit model of congestive heart failure.
    Ning B; Qi X; Li Y; Liu H; Zhang F; Qin C
    Cell Physiol Biochem; 2014; 33(5):1389-99. PubMed ID: 24853498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac contractility modulation therapy in advanced systolic heart failure.
    Lyon AR; Samara MA; Feldman DS
    Nat Rev Cardiol; 2013 Oct; 10(10):584-98. PubMed ID: 23939481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure.
    Borggrefe M; Burkhoff D
    Eur J Heart Fail; 2012 Jul; 14(7):703-12. PubMed ID: 22696514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durations.
    Zhang Q; Chan YS; Liang YJ; Fang F; Lam YY; Chan CP; Lee AP; Chan KC; Wu EB; Yu CM
    Int J Cardiol; 2013 Aug; 167(3):889-93. PubMed ID: 22330007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure.
    Sabbah HN; Chandler MP; Mishima T; Suzuki G; Chaudhry P; Nass O; Biesiadecki BJ; Blackburn B; Wolff A; Stanley WC
    J Card Fail; 2002 Dec; 8(6):416-22. PubMed ID: 12528095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional significance of presynaptic alpha-adrenergic receptors in failing and nonfailing human left ventricle.
    Parker JD; Newton GE; Landzberg JS; Floras JS; Colucci WS
    Circulation; 1995 Oct; 92(7):1793-800. PubMed ID: 7671363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.